Loading…
Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects
Epidemiological data predict a dramatic increase in the prevalence of diabetes and of diabetic retinopathy (DR) – the most common complication of diabetes-for which however we do not have so far effective tools for prevention and treatment. Since hypovitaminosis D is very frequent in patients with d...
Saved in:
Published in: | Reviews in endocrine & metabolic disorders 2021-12, Vol.22 (4), p.715-727 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c540t-9ba690312a712133fa8ced3362e2d6bdbb5a942dd6ff1091cb463a4ec11df1a73 |
---|---|
cites | cdi_FETCH-LOGICAL-c540t-9ba690312a712133fa8ced3362e2d6bdbb5a942dd6ff1091cb463a4ec11df1a73 |
container_end_page | 727 |
container_issue | 4 |
container_start_page | 715 |
container_title | Reviews in endocrine & metabolic disorders |
container_volume | 22 |
creator | Tecilazich, Francesco Formenti, Anna Maria Giustina, Andrea |
description | Epidemiological data predict a dramatic increase in the prevalence of diabetes and of diabetic retinopathy (DR) – the most common complication of diabetes-for which however we do not have so far effective tools for prevention and treatment. Since hypovitaminosis D is very frequent in patients with diabetes and vitamin D (VD) has vascular protective properties, several studies have addressed the association of VD deficiency with DR and its severity and progression, whereas the effects of VD supplementation on its natural history are largely unknown. Here we review the available evidence that supports the possible protective role of VD in DR and suggests to determine the VD levels in DR patients calling for a definitive randomized clinical trial to ascertain whether VD supplementation could protect against DR. |
doi_str_mv | 10.1007/s11154-020-09575-4 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7538371</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2449182486</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-9ba690312a712133fa8ced3362e2d6bdbb5a942dd6ff1091cb463a4ec11df1a73</originalsourceid><addsrcrecordid>eNp9kU1P3DAQhq0KVCjlD_SAInHhkuLxV-IekBD9QkKiQnC2HNvZNcraqZ1F2n-PS4ACBy4zY80zr2f0IvQF8FfAuDnOAMBZjQmuseQNr9kHtAu8oTURWGyVmraylsD5DvqU8y3GBITkH9EOpZgILttddHUVB1fFvrrzk175UH2vSrBed27ypkolhjjqabn5Vv0pKY7LTfZxiAtv9FDpYCsz-DA_8ujMlD-j7V4P2e0_5j108_PH9dnv-uLy1_nZ6UVtOMNTLTstJKZAdAMEKO11a5ylVBBHrOhs13EtGbFW9D1gCaZjgmrmDIDtQTd0D53MuuO6WzlrXJiSHtSY_EqnjYraq9ed4JdqEe9Uw2lLGygCR48CKf5duzyplc_GDYMOLq6zIoxJaAlrRUEP36C3cZ1COU8RAVxi2XBeKDJTJsWck-uflwGs_lmmZstUsUw9WKZYGTp4ecbzyJNHBaAzkEsrLFz6__c7svdOcaLD</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2615909755</pqid></control><display><type>article</type><title>Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects</title><source>Springer Nature</source><creator>Tecilazich, Francesco ; Formenti, Anna Maria ; Giustina, Andrea</creator><creatorcontrib>Tecilazich, Francesco ; Formenti, Anna Maria ; Giustina, Andrea</creatorcontrib><description>Epidemiological data predict a dramatic increase in the prevalence of diabetes and of diabetic retinopathy (DR) – the most common complication of diabetes-for which however we do not have so far effective tools for prevention and treatment. Since hypovitaminosis D is very frequent in patients with diabetes and vitamin D (VD) has vascular protective properties, several studies have addressed the association of VD deficiency with DR and its severity and progression, whereas the effects of VD supplementation on its natural history are largely unknown. Here we review the available evidence that supports the possible protective role of VD in DR and suggests to determine the VD levels in DR patients calling for a definitive randomized clinical trial to ascertain whether VD supplementation could protect against DR.</description><identifier>ISSN: 1389-9155</identifier><identifier>ISSN: 1573-2606</identifier><identifier>EISSN: 1573-2606</identifier><identifier>DOI: 10.1007/s11154-020-09575-4</identifier><identifier>PMID: 33026598</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Clinical aspects ; Diabetes ; Diabetes Mellitus ; Diabetic retinopathy ; Diabetic Retinopathy - epidemiology ; Endocrinology ; Epidemiology ; Humans ; Internal Medicine ; Medicine ; Medicine & Public Health ; Patients ; Randomized Controlled Trials as Topic ; Retinopathy ; Supplements ; Vitamin D ; Vitamin D - therapeutic use ; Vitamin D Deficiency - complications ; Vitamin D Deficiency - epidemiology ; Vitamin deficiency</subject><ispartof>Reviews in endocrine & metabolic disorders, 2021-12, Vol.22 (4), p.715-727</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>2020. Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-9ba690312a712133fa8ced3362e2d6bdbb5a942dd6ff1091cb463a4ec11df1a73</citedby><cites>FETCH-LOGICAL-c540t-9ba690312a712133fa8ced3362e2d6bdbb5a942dd6ff1091cb463a4ec11df1a73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33026598$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tecilazich, Francesco</creatorcontrib><creatorcontrib>Formenti, Anna Maria</creatorcontrib><creatorcontrib>Giustina, Andrea</creatorcontrib><title>Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects</title><title>Reviews in endocrine & metabolic disorders</title><addtitle>Rev Endocr Metab Disord</addtitle><addtitle>Rev Endocr Metab Disord</addtitle><description>Epidemiological data predict a dramatic increase in the prevalence of diabetes and of diabetic retinopathy (DR) – the most common complication of diabetes-for which however we do not have so far effective tools for prevention and treatment. Since hypovitaminosis D is very frequent in patients with diabetes and vitamin D (VD) has vascular protective properties, several studies have addressed the association of VD deficiency with DR and its severity and progression, whereas the effects of VD supplementation on its natural history are largely unknown. Here we review the available evidence that supports the possible protective role of VD in DR and suggests to determine the VD levels in DR patients calling for a definitive randomized clinical trial to ascertain whether VD supplementation could protect against DR.</description><subject>Clinical aspects</subject><subject>Diabetes</subject><subject>Diabetes Mellitus</subject><subject>Diabetic retinopathy</subject><subject>Diabetic Retinopathy - epidemiology</subject><subject>Endocrinology</subject><subject>Epidemiology</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Patients</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Retinopathy</subject><subject>Supplements</subject><subject>Vitamin D</subject><subject>Vitamin D - therapeutic use</subject><subject>Vitamin D Deficiency - complications</subject><subject>Vitamin D Deficiency - epidemiology</subject><subject>Vitamin deficiency</subject><issn>1389-9155</issn><issn>1573-2606</issn><issn>1573-2606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kU1P3DAQhq0KVCjlD_SAInHhkuLxV-IekBD9QkKiQnC2HNvZNcraqZ1F2n-PS4ACBy4zY80zr2f0IvQF8FfAuDnOAMBZjQmuseQNr9kHtAu8oTURWGyVmraylsD5DvqU8y3GBITkH9EOpZgILttddHUVB1fFvrrzk175UH2vSrBed27ypkolhjjqabn5Vv0pKY7LTfZxiAtv9FDpYCsz-DA_8ujMlD-j7V4P2e0_5j108_PH9dnv-uLy1_nZ6UVtOMNTLTstJKZAdAMEKO11a5ylVBBHrOhs13EtGbFW9D1gCaZjgmrmDIDtQTd0D53MuuO6WzlrXJiSHtSY_EqnjYraq9ed4JdqEe9Uw2lLGygCR48CKf5duzyplc_GDYMOLq6zIoxJaAlrRUEP36C3cZ1COU8RAVxi2XBeKDJTJsWck-uflwGs_lmmZstUsUw9WKZYGTp4ecbzyJNHBaAzkEsrLFz6__c7svdOcaLD</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Tecilazich, Francesco</creator><creator>Formenti, Anna Maria</creator><creator>Giustina, Andrea</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211201</creationdate><title>Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects</title><author>Tecilazich, Francesco ; Formenti, Anna Maria ; Giustina, Andrea</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-9ba690312a712133fa8ced3362e2d6bdbb5a942dd6ff1091cb463a4ec11df1a73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Clinical aspects</topic><topic>Diabetes</topic><topic>Diabetes Mellitus</topic><topic>Diabetic retinopathy</topic><topic>Diabetic Retinopathy - epidemiology</topic><topic>Endocrinology</topic><topic>Epidemiology</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Patients</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Retinopathy</topic><topic>Supplements</topic><topic>Vitamin D</topic><topic>Vitamin D - therapeutic use</topic><topic>Vitamin D Deficiency - complications</topic><topic>Vitamin D Deficiency - epidemiology</topic><topic>Vitamin deficiency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tecilazich, Francesco</creatorcontrib><creatorcontrib>Formenti, Anna Maria</creatorcontrib><creatorcontrib>Giustina, Andrea</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Reviews in endocrine & metabolic disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tecilazich, Francesco</au><au>Formenti, Anna Maria</au><au>Giustina, Andrea</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects</atitle><jtitle>Reviews in endocrine & metabolic disorders</jtitle><stitle>Rev Endocr Metab Disord</stitle><addtitle>Rev Endocr Metab Disord</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>22</volume><issue>4</issue><spage>715</spage><epage>727</epage><pages>715-727</pages><issn>1389-9155</issn><issn>1573-2606</issn><eissn>1573-2606</eissn><abstract>Epidemiological data predict a dramatic increase in the prevalence of diabetes and of diabetic retinopathy (DR) – the most common complication of diabetes-for which however we do not have so far effective tools for prevention and treatment. Since hypovitaminosis D is very frequent in patients with diabetes and vitamin D (VD) has vascular protective properties, several studies have addressed the association of VD deficiency with DR and its severity and progression, whereas the effects of VD supplementation on its natural history are largely unknown. Here we review the available evidence that supports the possible protective role of VD in DR and suggests to determine the VD levels in DR patients calling for a definitive randomized clinical trial to ascertain whether VD supplementation could protect against DR.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>33026598</pmid><doi>10.1007/s11154-020-09575-4</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1389-9155 |
ispartof | Reviews in endocrine & metabolic disorders, 2021-12, Vol.22 (4), p.715-727 |
issn | 1389-9155 1573-2606 1573-2606 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7538371 |
source | Springer Nature |
subjects | Clinical aspects Diabetes Diabetes Mellitus Diabetic retinopathy Diabetic Retinopathy - epidemiology Endocrinology Epidemiology Humans Internal Medicine Medicine Medicine & Public Health Patients Randomized Controlled Trials as Topic Retinopathy Supplements Vitamin D Vitamin D - therapeutic use Vitamin D Deficiency - complications Vitamin D Deficiency - epidemiology Vitamin deficiency |
title | Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A22%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20vitamin%20D%20in%20diabetic%20retinopathy:%20Pathophysiological%20and%20clinical%20aspects&rft.jtitle=Reviews%20in%20endocrine%20&%20metabolic%20disorders&rft.au=Tecilazich,%20Francesco&rft.date=2021-12-01&rft.volume=22&rft.issue=4&rft.spage=715&rft.epage=727&rft.pages=715-727&rft.issn=1389-9155&rft.eissn=1573-2606&rft_id=info:doi/10.1007/s11154-020-09575-4&rft_dat=%3Cproquest_pubme%3E2449182486%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-9ba690312a712133fa8ced3362e2d6bdbb5a942dd6ff1091cb463a4ec11df1a73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2615909755&rft_id=info:pmid/33026598&rfr_iscdi=true |